Apogee Therapeutics, Inc. ($APGE)
Filing Information
| Accession Number | 0001104659-26-039709 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 4, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
13,750
Total Value
$560,916.54
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Apr 1, 2026 | Exercise/Conversion | 4,125 | $22.86 | $94,297.50 | 213,898 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 1, 2026 | Sale | 2,698 | $84.31 | $227,468.38 | 211,200 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 1, 2026 | Sale | 2,702 | $85.33 | $230,561.66 | 208,498 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 1, 2026 | Sale | 100 | $85.89 | $8,589.00 | 208,398 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Apr 1, 2026 | Exercise/Conversion | 4,125 | $0.00 | $0.00 | 127,165 | Direct | โ | View Details |